Idan Elmelech insider trades

Open-market stock purchases and sales by Idan Elmelech, COO & Principal Financial Ofcr at BridgeBio Oncology Therapeutics, Inc, from SEC Form 4 filings since May 10, 2026.

Recent trades

DateStockTradeValue
Oct 1, 2026BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)$1.4K
Jul 1, 2026BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)$2.7K
May 10, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—

Companies traded

  • BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Oct 1, 2026

Get free alerts when Idan Elmelech files a new trade →